Funding Rounds
Neogene Therapeutics

Neogene Therapeutics Series A (2019, $15M)

Neogene Therapeutics

Neo-antigen T cell therapies developer to treat cancer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 71,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $15.00M